Juvena Therapeutics

CEO Dr. Hanadie Yousef looks forward to representing Juvena at Boston CEO on October 28-29, hosted by Longwood Healthcare Leaders. She will discuss how Juvena is utilizing cutting-edge technologies, including the latest in AI and quantitative proteomics to advance tissue restorative biologics. Leanr more and register at: https://lnkd.in/eehfZ2xB

Our CEO, Dr. Hanadie Yousef had a great time at our major investor Bison Ventures's AGM in Seattle last week! She enjoyed meeting many of the firm's LPs and impressive Deep Tech portfolio company founders. In founding Juvena, some of the most important decisions our leadership team has made is in picking investors who aligned with our values and our approach. We’re fortunate to have found investors who truly support our mission and our growth. Thank you to the team at Bison for the opportunity to reflect on our experiences in AI-driven drug discovery and development, and the secrets to our success along with inspiring and impressive industry leaders. And thank you to our CEO Hanadie Yousef's co-panelists, Bruce Beutel, CEO of Passkey Therapeutics, and Andrei Georgescu, Ph.D., CEO of Vivodyne, and our awesome moderator, Caleb Appleton! Thanks to Bison's founders, Ben Hemani and Tom Biegala for believing in Juvena and picking us as their first portfolio company as they launched their first fund, and built the firm from the ground up to invest in frontier technology companies addressing some of the world's most pressing challenges!

Team Potluck We wrapped up last week with an incredible team potluck and some fantastic team-building activities! 🥳 From delicious dishes shared by our culturally diverse team to engaging activities that brought out our collaborative spirit, it was an afternoon filled with fun, laughter and connection. A huge thank you to our People and Culture Team Leaders Bek Madjidov, Jamie Romero, Natalie Ploof, and TeamBuilding ROI for helping us build stronger bonds and making the experience unforgettable! Check out the photos and activities we enjoyed 💼🎉 #Juvena #WorkHardPlayHard #Team #Potluck #Fun

16th Drug Discovery Strategic Summit We are thrilled to share that our Director of Discovery and Platform, Thach Mai, and our Director of Translational Biology, Priya Handa, PhD, represented Juvena Therapeutics at the 16th Drug Discovery Strategic Summit in San Francisco. Thach discussed our AI-enabled platform for therapeutic discovery, while Priya presented on JUV-112, a novel approach to weight loss and metabolic health. It was a thought provoking event filled with insights and valuable connections in the field of drug discovery. #Science #Summit #Juvena

We are excited that our Director of Discovery and Platform, Thach Mai, and our Director of Translational Biology, Priya Handa, PhD, will be attending the 16th Drug Discovery Strategic Summit in San Francisco on October 9-10, 2024! Thach will be presenting on "AI-enabled drug discovery platform for mapping the therapeutic potential of stem cell secreted proteins" from 9:00-9:20AM on October 9, and Priya will be presenting on "JUV-112 Offers a Distinctive Approach to Weight Loss and Metabolic Health" from 1:35-1:55PM on October 10. We are thrilled to engage with industry leaders and showcase our commitment to developing biologics that restore tissue function and rejuvenate lives. To learn more: https://lnkd.in/e7qtzxcA #Science #Summit #Juvena

Today is the 4th annual International #MyotonicDystrophy Awareness Day! Juvena is excited to be developing a first in class biologic that promotes muscle regeneration and function, with the ultimate goal of rejuvenating the lives of those living with Myotonic Dystrophy and other myopathies.

Celebrating Our Interns Since launching our annual internship program in 2018, we have had bright, ambitious interns who have contributed significantly to Juvena’s success. We are proud to announce the completion of 2024 internships, where our interns Mai Al Shaaban and Arjun Shivkumar gained valuable hands-on experience and fresh perspectives that drive our science forward. Juvena’s internship program continues to be an essential part of our commitment to developing the next generation of scientists and leaders. Whether you are a student looking to gain real-world experience or an aspiring professional seeking to sharpen your skills, Juvena remains dedicated to providing an active and enriching internship experience. Many thanks to our amazing Mingyu Chung and Rohit Jadhav, Ph.D. for hosting our bright interns this year! #InternshipProgram #InternshipOpportunities #Juvena

Join Juvena Therapeutics and the Myotonic Dystrophy Foundation (MDF) THIS Friday July 19, 2024 at 12pm PT for the next MDF "Meet the Drug Developers" webinar, where Juvena will present information about our innovative, muscle regenerating JUV-161 protein therapeutic candidate! JUV-161 acts as the "insulin of muscle" and has the potential to improve the lives of those living with DM1 by regenerating lost muscle tissue, improving muscle metabolism, and reducing inflammation. JUV-161 is scheduled to enter clinical trials with healthy volunteers in September 2024, with Phase 2 trials for DM1 patients scheduled for 2025. Webinar preregistration is required. Register now to learn more! https://lnkd.in/edqRYKxj

The Juvena team's annual 2024 summer social was a blast! We celebrated Juvena's achievements and our team members' commitments to our Core Values: Passion, Accountability, Respect, Inclusion, and Excellence!

June videos of our CEO, Dr. Hanadie Yousef giving talks and on panels representing Juvena are available! - AFAR: AI For Longevity Drug Discovery: Breakthrough and Challenges Webinar: https://lnkd.in/eynm24Gx - Longevity Summit Dublin: https://lnkd.in/gXXc4bJk - BIO SD Jun 2024, "Longevity Therapeutics Enter Biopharma Mainstream": https://lnkd.in/gGNpQjKM - WEF AMNC2024, "Letting Biotech Breath": https://lnkd.in/gFUY5Anq